| Description | This mouse recombinant antibody has been developed to specifically bind to human BST2. The epitope recognized by this antibody is the amino acid sequence EVERLRRENQVLSVR, and it exhibits a high affinity of 0.1 nM for human BST2. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human |
| Immunogen | 293T cells introduced with the human BST2D gene. |
| Epitope | EVERLRRENQVLSVR, corresponds to the region from positions 133 to 147 of BST2D |
| Affinity | KD = 0.1 nM |
| Isotype | Mouse IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein G affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | FC; ICC; WB |
| Application Notes | FC: 1 μg/mL |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | BST2 |
| Alternative Name | Bone Marrow Stromal Cell Antigen 2; HM1.24 Antigen; TETHERIN; BST-2; Bone Marrow Stromal Antigen 2; CD317 Antigen; NPC-A-7; CD317 |
| Gene ID | 684 |
| UniProt | Q10589 |
| Related pathway | Infectious disease and SARS-CoV-1-host interactions |
| Research Area | Cancer Research |
| Related Disease | Cancer |
